The search for replicable markers -biological, psycho logical, social or their combinations -for psychiatric ill nesses carries on. In psychosis, attention has been directed to atrisk and firstepisode populations, given the possibility that following markers in young people will avoid the con founds of chronicity and exposure to pharmacological treat ments. A variety of promising biomarkers have been evalu ated, but few have passed through the rigorous screens of broader replication and demonstrated clinical utility.
The search for replicable markers -biological, psycho logical, social or their combinations -for psychiatric ill nesses carries on. In psychosis, attention has been directed to atrisk and firstepisode populations, given the possibility that following markers in young people will avoid the con founds of chronicity and exposure to pharmacological treat ments. A variety of promising biomarkers have been evalu ated, but few have passed through the rigorous screens of broader replication and demonstrated clinical utility. 1, 2 We argue in this editorial that such difficulties are unsur prising, given the construction of current studies and the fact that such disorders typically develop in adolescence and young adulthood. This "critical period" 3 for risk and onset of major youth mental illnesses, such as psychosis, coincides with deeply interlaced neurobiological, clinical, affective and cognitive development, not to mention profound changes in social interactions and exposures. We explore the implica tions of this backdrop, including how it should inform both the search for biomarkers and the design of future studies.
Critical periods, neurobiology and mental health
Adolescence to early adulthood, the age range when the early course of psychotic illness is most likely to emerge, is a win dow in which much is dynamic. At a neurobiological level, this includes neurons and synapses, neurotransmission, tro phic factors and longterm potentiation, among other phe nomena. 4 However, it is also a period of sexual maturation, exposure to novel social and physical environments, different forms of stress, new models and contexts for learning, and de veloping cognitive abilities, reasoning and affective states. 5 Whether adaptive or maladaptive, changes in brain structure and function are believed to occur in response to these inter nal and external stimuli and demands. For example, the fre quency and type of stressful life events change as children enter adolescence; 6 with these changes come further altera tions in neurobiology that may denote increased sensitization to such stimuli. 7 If more persistently dysregulated during a critical window, the longterm setpoints of neurobiological processes or pathways may become distorted. Neurodevelop ment that results from interactions between endogenous neu robiological elements and exogenous environmental factors could thus profoundly alter brain processes, leading to differ ential trajectories and clinical outcomes.
Neurobiology, biomarkers and endophenotypes
The acknowledgement that biological, psychological and social markers are not static but may themselves be subject to critical periods of influence or change, especially in youth mental health, suggests a path forward. Rather than relying on "snap shots" of data at a single time point to differentiate groups or pathology, it draws attention to the dynamic trajectories of indi vidual markers and how they change. As individuals pass through periods of heightened risk, sequential evaluation of 1 or more markers could bring to light differential courses or inflec tion points that relate to specific clinical or functional outcomes.
The suggestion that neurodevelopmental alterations may cut across traditional psychiatric diagnostic schemas (such as DSM categories) 8 dovetails with major contemporary neuro science initiatives. In response to the perceived failure of symptombased classification, the National Institute of Mental Health Research Domain Criteria (RDoC) were pioneered to "reimagine" classification systems agnostic of traditional diag nostic schema. 9 To advance the study and treatment of mental illness, RDoC advocates argue that we must identify and focus on valence systems, cognition, social processing, and arousal and regulatory systems across multiple levels of analysisfrom genes and molecules to circuitry and (ultimately) behav iour. Similarly, the endophenotype concept has been articu lated as a means of deconstructing unseen but measurable components "along the pathway" between genotype and syn dromic illness. 10 Endophenotypes are heritable traits that cosegregate with illness, but similar to RDoC categories can be explored at any level of analysis. While neither of these initia tives is without controversy, 11, 12 recent consortia in psychosis studies openly endorse either or both of them. 13, 14 In the context of youth mental health, RDoC or endophenotypebased approaches could therefore shape our under standing of how psychobiological markers change over time in young people at varying degrees of risk for psychosis and link them to differential clinical, functional or other end points. Since the longitudinal trajectories of these markers may reveal more about pathogenesis and outcome than static ones, we argue that the focus should shift to the "dynamic" nature of endophenotypes and markers. Ultimately, it is likely that com binations of these markers measured longitudinally, not just single ones, will best map onto trajectories and outcomes. In the remainder of this editorial, we provide brief examples of 4 such markers and explore their implications for early psychosis.
Dynamic endophenotypes and biomarkers

Structural neuroimaging
The increasing use of longitudinal and repeated neuroim aging measures has allowed for the documentation of pro gressive brain changes in individuals with schizophrenia, re flecting the dynamic central nervous system. [15] [16] [17] In a more homogeneous sample of patients with firstepisode schizo phrenia, Andreasen and colleagues 18, 19 found progressive grey and white matter loss in multiple regions over time related to the severity of psychotic symptoms, relapse duration and anti psychotic treatment intensity. The presence and persist ence of negative symptoms in patients with schizophrenia and related psychoses is also associated with abnormalities in cortical thickness 20 and white matter, 21, 22 cognitive deficits, and poor functional and vocational outcomes. 23, 24 Studies ex amining how putative endophenotypes interact and lead to differential effects on brain structure and functioning are therefore much needed. For example, in individuals at clinical high risk for psychosis, both negative symptoms and progres sive cortical changes are frequently seen. 25, 26 This approach could derive clinical utility from imaging findings by enabling the early identification and targeted clinical followup of those likely to experience less favourable outcomes.
Advanced imaging techniques
Continuing innovations in neuroimaging 27 have generated image processing techniques that capture salient alterations in brain structure at the group level 28 and statistical tech niques that are robust to uneven sampling among study par ticipants. 29 Longitudinal designs can thus improve statistical power for detecting group differences in neuroanatomical trajectories, allowing for the investigation of novel endo phenotypes. For example, shape metrics are heritable and may have alterations specific to schizophrenia. 30 Such method ologies provide insight into subcortical structures (such as the striatum) that are especially subject to confound ing effects, or where standard volumetric comparisons fail to elucidate group differences. These metrics are also more sen sitive to the progressive changes in neuroanatomy that char acterize adolescent maturation. 31 Advanced statistical, graph theory and community detection techniques are beginning to be used to infer underlying connectivity between brain re gions, 27 with adaptations of these methods to understand brain maturation. 32, 33 Future work will need to connect these different levels of observation into an integrated model. 34 Ad vanced imaging techniques could provide novel insight into a variety of microscopiclevel alterations in neuroanatomyvaluable indices for the study of progressive brain changes underlying the onset of psychosis.
35-37
Sleep alterations
Among the most profound changes occurring during adoles cence is a diminution in the amount of deep sleep: Δ (1-4 Hz) electroencephalography power in nonrapid eye movement sleep declines massively during adolescence. 38 It was on this basis that Feinberg 39 originally advanced the neurodevelop mental hypothesis of schizophrenia, postulating that such alterations in sleep architecture correlate with synaptic prun ing and maturation. Important changes in sleep patterns also take place during adolescence, notably a physiologic phase delay in the circadian rhythm. A dynamic defect in these maturational processes could be tracked over time and may offer another window to explore markers of risk for the emergence of psychotic symptoms. 40 This is particularly rele vant given emerging literature that sleep disorders are pre sent in atrisk and firstepisode phases of psychosis [41] [42] [43] and are often early warning signs that precede the onset of illness or indicate relapse.
Stress reactivity
The hypothalamic-pituitary-adrenal axis harbours key markers of stress response and undergoes significant change during and after puberty. 44 In psychosis, stress reactivity has been posited as a putative endophenotype owing to its co segregation with illness and potential trait status in unaf fected relatives. 45 Welldesigned laboratorybased paradigms have demonstrated shortterm blunting of the dynamic corti sol response to stress, 46, 47 which may reflect exhaustion of the potential for a (healthy) robust phasic response to stress alongside the more tonic elevation found in atrisk popula tions. 48 However, key questions remain about whether blunted stress response is a trait consistently found in unaf fected family members and how the observed association be tween low tonic and robust phasic activity in healthy individ uals changes along with longitudinal outcomes.
Challenges and conclusions
The examples we have discussed illustrate how putative endophenotypes could change dynamically over time -a phenomenon that would benefit from longitudinal studies. Such an approach presents 2 kinds of challenges. The first of these is concerned with theory and science: markers may diverge or change at different time points and rates; given J Psychiatry Neurosci 2016;41(3) this background variation, how and at what thresholds should risk for a particular trajectory be flagged or treated? Will change be expressed as linear, stepwise, cyclical, or in other forms? How can baseline states be indexed and/or maladaptive changes be determined in the context of already changing neurobiology -by age, phase of sexual matura tion, clinical stage or otherwise? A necessary next step here is for withinsubject changes in biomarkers to be correlated with longitudinal clinical/functional observations, making it plausible to weed out spurious correlations or to derive the presumably heterogeneous pathways to illness or resolution.
A second set of challenges relates to the clinical applicability of this approach. For individuals in early stages of mental dis tress or subclinical illness, it is likely that single biomarkers/ endophenotype trajectories will present as abnormal while an overall panel will remain ambiguous. Such a scenario should trigger closer monitoring and clinical correlation over time to either worsening or resolution of biomarkers and outcomes. In later (clinical highrisk or firstepisode) stages, biomarker panels may become increasingly abnormal, prompting more intensive interventions with different risk/benefit profiles. It will there fore be important to identify and follow overlapping cohorts with varying degrees of enrichment for risk in order to under stand whether putative endophenotypes better align with a priori risk groupings or evolving clinical/functional outcomes.
Finally, are youth mental health services capable of han dling an integrative and coordinated approach given current resource constraints? At the research stage, intensive assay ing at frequent time points is necessary. Ultimately, however, we envision the use of biomarkers not as a standard tool to be applied uniformly at great cost, but as a measured and tar geted approach that can be selected to guide risk assessments or treatment decisions at key branchpoints. And the eco nomic arguments to fund "preemptive" clinical infrastruc tures are beginning to be made. 49 Recent developments aimed at transforming youth mental health systems, 50 includ ing in Canada, 51 will almost certainly involve atrisk popula tions beyond DSMspecific diagnoses. 52 They now promise to form a scaffolding in which highquality and research informed services ready to take up knowledge about dy namic endophenotypes can be situated.
